MarketBeat Instant News Alerts 2 hours agoFifth Third Bancorp (NASDAQ:FITB) Issues Earnings Results, Beats Estimates By $0.04 EPSMarketBeatFifth Third Bancorp (NASDAQ:FITB - Get Free Report) issued its quarterly earnings data on Friday. The financial services provider reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The business had revenue of $2.31 billion during the quarter, compared to analyst estimates of $2.28 billion. Fifth Third Bancorp had a net margin of 17.97% and a return on equity of 13.31%. During the same quarter last year, the business earned $0.78 EPS. NASDAQ:FITBRead Fifth Third Bancorp (NASDAQ:FITB) Issues Earnings Results, Beats Estimates By $0.04 EPS2 hours agoTruist Financial (NYSE:TFC) Posts Earnings Results, Beats Estimates By $0.05 EPSMarketBeatTruist Financial (NYSE:TFC - Get Free Report) released its earnings results on Friday. The insurance provider reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.99 by $0.05. Truist Financial had a net margin of 16.82% and a return on equity of 8.69%. The company had revenue of $5.24 billion for the quarter, compared to analyst estimates of $5.20 billion. During the same period in the prior year, the firm earned $0.97 EPS. NYSE:TFCRead Truist Financial (NYSE:TFC) Posts Earnings Results, Beats Estimates By $0.05 EPS2 hours agoWedbush Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) StockMarketBeatWedbush raised their target price on shares of Artiva Biotherapeutics from $18.00 to $23.00 and gave the company an "outperform" rating in a research note on Friday.NASDAQ:ARTVRead Wedbush Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) Stock2 hours agoDisc Medicine (NASDAQ:IRON) Price Target Raised to $110.00MarketBeatWedbush increased their price target on shares of Disc Medicine from $90.00 to $110.00 and gave the stock an "outperform" rating in a research report on Friday.NASDAQ:IRONRead Disc Medicine (NASDAQ:IRON) Price Target Raised to $110.002 hours agoRevolution Medicines' (RVMD) Outperform Rating Reiterated at WedbushMarketBeatWedbush reaffirmed an "outperform" rating and issued a $77.00 price target on shares of Revolution Medicines in a research note on Friday.NASDAQ:RVMDRead Revolution Medicines' (RVMD) Outperform Rating Reiterated at Wedbush2 hours agoStephens Issues Positive Forecast for Bunge Global (NYSE:BG) Stock PriceMarketBeatStephens upped their target price on Bunge Global from $85.00 to $115.00 and gave the stock an "overweight" rating in a research report on Friday.NYSE:BGRead Stephens Issues Positive Forecast for Bunge Global (NYSE:BG) Stock Price Trending News1NVIDIA (NASDAQ:NVDA) Stock Price Down 4.4% - Here's Why2Traders Purchase Large Volume of Tilray Brands Call Options (NASDAQ:TLRY)3Stock Traders Purchase Large Volume of Plug Power Call Options (NASDAQ:PLUG)4ARM (NASDAQ:ARM) Shares Up 11.1% - Here's What Happened5Astera Labs (NASDAQ:ALAB) Shares Gap Down - Here's What Happened6QuantumScape (NYSE:QS) Trading Down 9% - Here's What Happened7Best Penny Stocks To Add to Your Watchlist - October 13th8Intel Corporation $INTC Shares Sold by Northwest Capital Management Inc All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoBP (NYSE:BP) Earns Equal Weight Rating from Analysts at Wells Fargo & CompanyMarketBeatNYSE:BPRead BP (NYSE:BP) Earns Equal Weight Rating from Analysts at Wells Fargo & Company2 hours agoConocoPhillips (NYSE:COP) Coverage Initiated at Wells Fargo & CompanyMarketBeatNYSE:COPRead ConocoPhillips (NYSE:COP) Coverage Initiated at Wells Fargo & Company2 hours agoJefferies Financial Group (NYSE:JEF) Price Target Cut to $55.00 by Analysts at BMO Capital MarketsMarketBeatNYSE:JEFRead Jefferies Financial Group (NYSE:JEF) Price Target Cut to $55.00 by Analysts at BMO Capital Markets2 hours agoOccidental Petroleum (NYSE:OXY) Now Covered by Wells Fargo & CompanyMarketBeatNYSE:OXYRead Occidental Petroleum (NYSE:OXY) Now Covered by Wells Fargo & Company2 hours agoShell (NYSE:SHEL) Earns Equal Weight Rating from Analysts at Wells Fargo & CompanyMarketBeatNYSE:SHELRead Shell (NYSE:SHEL) Earns Equal Weight Rating from Analysts at Wells Fargo & Company2 hours agoValero Energy (NYSE:VLO) Now Covered by Wells Fargo & CompanyMarketBeatNYSE:VLORead Valero Energy (NYSE:VLO) Now Covered by Wells Fargo & Company2 hours agoUnusual Machines (NYSEAMERICAN:UMAC) Receives "Buy" Rating from Needham & Company LLCMarketBeatNYSEAMERICAN:UMACRead Unusual Machines (NYSEAMERICAN:UMAC) Receives "Buy" Rating from Needham & Company LLC2 hours agoVeeva Systems' (VEEV) "Buy" Rating Reiterated at Needham & Company LLCMarketBeatNYSE:VEEVRead Veeva Systems' (VEEV) "Buy" Rating Reiterated at Needham & Company LLC2 hours agoVeeva Systems' (VEEV) Buy Rating Reaffirmed at BTIG ResearchMarketBeatNYSE:VEEVRead Veeva Systems' (VEEV) Buy Rating Reaffirmed at BTIG Research2 hours agoU.S. Bancorp (NYSE:USB) Price Target Raised to $55.00 at Bank of AmericaMarketBeatNYSE:USBRead U.S. Bancorp (NYSE:USB) Price Target Raised to $55.00 at Bank of America2 hours agoRobert W. Baird Begins Coverage on Kontoor Brands (NYSE:KTB)MarketBeatNYSE:KTBRead Robert W. Baird Begins Coverage on Kontoor Brands (NYSE:KTB)2 hours agoBTIG Research Reiterates Buy Rating for Carvana (NYSE:CVNA)MarketBeatNYSE:CVNARead BTIG Research Reiterates Buy Rating for Carvana (NYSE:CVNA)2 hours agoZions Bancorporation, N.A. (NASDAQ:ZION) Upgraded by Robert W. Baird to Outperform RatingMarketBeatNASDAQ:ZIONRead Zions Bancorporation, N.A. (NASDAQ:ZION) Upgraded by Robert W. Baird to Outperform Rating2 hours agoTaysha Gene Therapies (NASDAQ:TSHA) Earns "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:TSHARead Taysha Gene Therapies (NASDAQ:TSHA) Earns "Buy" Rating from Needham & Company LLC2 hours agolululemon athletica (NASDAQ:LULU) Given Buy Rating at BTIG ResearchMarketBeatNASDAQ:LULURead lululemon athletica (NASDAQ:LULU) Given Buy Rating at BTIG Research2 hours agoLegend Biotech (NASDAQ:LEGN) Given New $60.00 Price Target at HC WainwrightMarketBeatNASDAQ:LEGNRead Legend Biotech (NASDAQ:LEGN) Given New $60.00 Price Target at HC Wainwright2 hours agoBank of America Issues Positive Forecast for Krystal Biotech (NASDAQ:KRYS) Stock PriceMarketBeatNASDAQ:KRYSRead Bank of America Issues Positive Forecast for Krystal Biotech (NASDAQ:KRYS) Stock Price2 hours agoArtiva Biotherapeutics (NASDAQ:ARTV) Receives "Buy" Rating from Needham & Company LLCMarketBeatNASDAQ:ARTVRead Artiva Biotherapeutics (NASDAQ:ARTV) Receives "Buy" Rating from Needham & Company LLC2 hours agoAppFolio (NASDAQ:APPF) Upgraded to Overweight at KeyCorpMarketBeatNASDAQ:APPFRead AppFolio (NASDAQ:APPF) Upgraded to Overweight at KeyCorp2 hours agoLithium Americas (TSE:LAC) Trading Down 21.6% - Here's What HappenedMarketBeatTSE:LACRead Lithium Americas (TSE:LAC) Trading Down 21.6% - Here's What Happened2 hours agoFerrexpo (LON:FXPO) Stock Price Up 11.7% - What's Next?MarketBeatLON:FXPORead Ferrexpo (LON:FXPO) Stock Price Up 11.7% - What's Next?2 hours agoFerrexpo (LON:FXPO) Trading Up 11.7% - Here's What HappenedMarketBeatLON:FXPORead Ferrexpo (LON:FXPO) Trading Up 11.7% - Here's What Happened2 hours agoThe Korea Fund, Inc. (NYSE:KF) Short Interest UpdateMarketBeatNYSE:KFRead The Korea Fund, Inc. (NYSE:KF) Short Interest Update2 hours agoSoluna Holdings, Inc. (NASDAQ:SLNH) Short Interest Down 77.2% in SeptemberMarketBeatNASDAQ:SLNHRead Soluna Holdings, Inc. (NASDAQ:SLNH) Short Interest Down 77.2% in September Featured Articles and OffersMicrosoft 365 Premium Marks the Next Phase of AI MonetizationBy Chris Markoch | October 12, 2025Move $1,000 into this stock before Nov 6From Altimetry (Ad)Why Congress Is Buying Intuitive Surgical Ahead of EarningsBy Gabriel Osorio-Mazilli | October 14, 20253 Rare Earth Stocks Powering America’s Critical Minerals BoomBy Ryan Hasson | October 16, 2025Palantir’s New Healthcare Deal Boosts AI and Data Reach By Chris Markoch | October 15, 2025Man Who Called Nvidia at $1.10 Says Buy This Now...From The Oxford Club (Ad)FICO’s Big Dip Could Be the Best Buying Chance of the YearBy Gabriel Osorio-Mazilli | October 13, 2025Salesforce’s Long-Awaited Inflection is Here: Rally On!By Thomas Hughes | October 16, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
